Effect of treatment with prostaglandin synthetase inhibitors on the erythrocyte sodium transport abnormality of Bartter's syndrome.
D000328:Adult; D001477:Bartter Syndrome / Q000097:blood* / Q000188:drug therapy; D001692:Biological Transport / Q000187:drug effects; D002675:Child, Preschool; D016861:Cyclooxygenase Inhibitors; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000097:blood*; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D012964:Sodium / Q000097:blood*
D016861:Cyclooxygenase Inhibitors; D010042:Ouabain; D012964:Sodium